US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Serina Therapeutics, Inc.

1.78

-0.0300-1.66%

Volume:14.66K

Turnover:26.08K

Market Cap:26.70M

PE:-0.89

High:1.79

Open:1.78

Low:1.76

Close:1.81

52wk High:7.92

52wk Low:1.22

Shares:15.00M

Float Shares:5.31M

Volume Ratio:0.28

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0109

EPS(LYR):-1.9100

ROE:-221.93%

ROA:-89.79%

PB:2.10

PE(LYR):-0.93

Loading ...

Overview Company News Filings

Serina Therapeutics director Karen J. Wilson acquires USD 37,000 common shares

Serina Therapeutics director Richard Peter Marshall buys USD 20,102 common shares

Serina Therapeutics files to sell 16.45M shares of common stock for holders

Serina Therapeutics Inc - Files to Register Resale of up to 16.5 Mln Common Shares by Selling Stockholder- SEC Filing

THOMSON REUTERS

Serina Therapeutics (SER) Gets a Buy from JonesTrading

Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks

Serina Therapeutics: Q1 EPS $-0.58

THOMSON REUTERS

Serina Therapeutics: Ser-252 Phase 1B Registrational Study Underway in Advanced Parkinson's Disease; Tfl Data Targeted for H1 2027

THOMSON REUTERS

Serina Therapeutics Q1 FY26 net loss widens to $6.9 million from Q1 FY25

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

SER Industries Gets BSE's Approval for Name Change

MT Newswires Live

Serina Therapeutics names Srini Tenjarla chief technology officer

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Serina Therapeutics presents POZ-based lipid nanoparticle data at LNP formulation summit

BRIEF-Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan

NYSE American accepts Serina plan to regain listing compliance by July 2027

Serina Therapeutics Announces Nyse American Acceptance of Continued Listing Compliance Plan

THOMSON REUTERS

Analysts’ Top Healthcare Picks: Serina Therapeutics (SER), Pharma Mar SA (PHMMF)

Serina Therapeutics, Inc FY Revenue USD 130 Thousand

THOMSON REUTERS

Serina Therapeutics FY2025 net loss widens 71.46% to $(19.2) million; revenue rises more than doubled to $130,000

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SER/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SER","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","market":"US","secType":"STK","nameCN":"Serina Therapeutics, Inc.","latestPrice":1.78,"timestamp":1780425830474,"preClose":1.81,"halted":0,"volume":14659,"delay":0,"changeRate":-0.01657458563535913,"floatShares":5311700,"shares":14997505,"eps":-2.0109,"marketStatus":"Trading","change":-0.03,"latestTime":"06-02 14:45:59 EDT","open":1.775,"high":1.79,"low":1.76,"amount":26078.8520765,"amplitude":0.016575,"askPrice":1.84,"askSize":200,"bidPrice":1.73,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-2.0109,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1780430400000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":1.81,"preHourTrading":{"tag":"盘前","latestPrice":1.896,"preClose":1.81,"latestTime":"05:16 EDT","volume":10,"amount":18.83,"timestamp":1780391767308,"change":0.086,"changeRate":0.047514,"amplitude":0.014365},"postHourTrading":{"tag":"盘后","latestPrice":1.67,"preClose":1.81,"latestTime":"19:59 EDT","volume":3354,"amount":5717.7322,"timestamp":1780358384742,"change":-0.14,"changeRate":-0.077348,"amplitude":0.105691},"volumeRatio":0.276504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","floatShares":5311700,"roa":"-89.79%","roe":"-221.93%","lyrEps":-1.91,"volumeRatio":0.276504,"shares":14997505,"dividePrice":0,"high":1.79,"amplitude":0.016575,"preClose":1.81,"low":1.76,"week52Low":1.22,"pbRate":"2.10","psRate":"205.35","week52High":7.92,"institutionHeld":0,"latestPrice":1.78,"committee":0.333333,"eps":-2.0109,"divideRate":0,"volume":14659,"delay":0,"ttmEps":-2.0109,"open":1.775,"prevYearClose":1.913,"prevWeekClose":1.84,"prevMonthClose":1.84,"prevQuarterClose":1.94,"fiveDayClose":1.92,"twentyDayClose":1.9,"sixtyDayClose":1.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SER\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-14","symbol":"SER","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2026-03-25","symbol":"SER","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-11-13","symbol":"SER","fiscalQuarterEnding":"2025/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"SER","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-03-24","symbol":"SER","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SER\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SER\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1752724800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SER\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SER","date":"2026-06-01","current":-0.87528,"percent":0.820952,"low":-65.600015,"twenty":-10.253923,"median":-5.054812,"eighty":-1.348125,"high":37.356482,"avg":-10.226588,"sd":19.93576,"marketCap":27413455},"quantilePoints":[{"date":"2024-04-05","current":29.141387,"twenty":30.584579,"median":32.083279,"eighty":33.732959,"marketCap":105541506},{"date":"2024-04-12","current":17.770243,"twenty":17.783016,"median":23.543628,"eighty":32.232039,"marketCap":93646584},{"date":"2024-04-19","current":17.456349,"twenty":17.731924,"median":17.945869,"eighty":31.172957,"marketCap":91992413},{"date":"2024-04-26","current":14.673941,"twenty":16.787882,"median":17.778226,"eighty":29.502185,"marketCap":77329529},{"date":"2024-05-03","current":14.209648,"twenty":14.673941,"median":17.57865,"eighty":21.283439,"marketCap":74882770},{"date":"2024-05-10","current":14.050147,"twenty":14.209648,"median":17.078432,"eighty":18.800885,"marketCap":74042223},{"date":"2024-05-17","current":12.820759,"twenty":14.187327,"median":15.966076,"eighty":18.090969,"marketCap":67563528},{"date":"2024-05-24","current":15.167772,"twenty":14.187327,"median":15.718602,"eighty":17.818141,"marketCap":79931945},{"date":"2024-05-31","current":-13.721878,"twenty":13.545619,"median":15.079879,"eighty":17.786209,"marketCap":79931945},{"date":"2024-06-07","current":-14.08298,"twenty":12.926135,"median":14.744671,"eighty":17.776629,"marketCap":82035417},{"date":"2024-06-14","current":-14.564515,"twenty":-13.557216,"median":14.673941,"eighty":17.770243,"marketCap":84840426},{"date":"2024-06-21","current":-15.922863,"twenty":-13.825876,"median":14.209648,"eighty":17.731924,"marketCap":92753004},{"date":"2024-06-28","current":-12.919404,"twenty":-13.944317,"median":14.209648,"eighty":17.655287,"marketCap":75257414},{"date":"2024-07-05","current":-11.364849,"twenty":-13.990538,"median":14.209648,"eighty":17.52973,"marketCap":66201907},{"date":"2024-07-12","current":-11.153551,"twenty":-13.799876,"median":13.810656,"eighty":17.339222,"marketCap":64971062},{"date":"2024-07-15","current":-13.477836,"twenty":-13.773877,"median":13.571165,"eighty":17.280659,"marketCap":78510363},{"date":"2024-08-02","current":-12.964682,"twenty":-13.747877,"median":13.539233,"eighty":17.222095,"marketCap":75521166},{"date":"2024-08-09","current":-11.364095,"twenty":-13.723872,"median":13.251843,"eighty":17.027373,"marketCap":66197511},{"date":"2024-08-16","current":-8.441425,"twenty":-13.721878,"median":2.384851,"eighty":16.171527,"marketCap":59150297},{"date":"2024-08-23","current":-10.330099,"twenty":-13.617881,"median":-8.582039,"eighty":15.966076,"marketCap":72384510},{"date":"2024-08-30","current":-10.13985,"twenty":-13.52255,"median":-9.00413,"eighty":15.966076,"marketCap":71051408},{"date":"2024-09-06","current":-10.104487,"twenty":-13.488788,"median":-9.975078,"eighty":15.85112,"marketCap":70803616},{"date":"2024-09-13","current":-7.831133,"twenty":-13.268937,"median":-9.379361,"eighty":15.707426,"marketCap":54873890},{"date":"2024-09-20","current":-7.554188,"twenty":-13.112179,"median":-8.839249,"eighty":15.365752,"marketCap":52933298},{"date":"2024-09-27","current":-9.43006,"twenty":-13.019016,"median":-9.049816,"eighty":15.0623,"marketCap":66077809},{"date":"2024-10-04","current":-8.251303,"twenty":-12.937515,"median":-8.845695,"eighty":14.905865,"marketCap":57818083},{"date":"2024-10-11","current":-8.580848,"twenty":-12.554189,"median":-8.732946,"eighty":14.786183,"marketCap":60127254},{"date":"2024-10-18","current":-9.769745,"twenty":-12.214089,"median":-8.764633,"eighty":14.702233,"marketCap":68458031},{"date":"2024-10-25","current":-8.872369,"twenty":-11.941393,"median":-8.872369,"eighty":14.673941,"marketCap":62169982},{"date":"2024-10-31","current":-8.568173,"twenty":-11.747964,"median":-8.847019,"eighty":14.628789,"marketCap":60038439},{"date":"2024-11-08","current":-5.742165,"twenty":-11.5456,"median":-8.764633,"eighty":14.420496,"marketCap":40236191},{"date":"2024-11-15","current":-6.048407,"twenty":-11.364849,"median":-8.720054,"eighty":14.209648,"marketCap":44459880},{"date":"2024-11-22","current":-5.928673,"twenty":-11.364547,"median":-8.695365,"eighty":14.209648,"marketCap":43570682},{"date":"2024-11-29","current":-6.352149,"twenty":-11.321986,"median":-8.600455,"eighty":14.209648,"marketCap":46682874},{"date":"2024-12-06","current":-7.456945,"twenty":-11.110513,"median":-8.568173,"eighty":14.187327,"marketCap":54802179},{"date":"2024-12-13","current":-6.006451,"twenty":-10.914992,"median":-8.561836,"eighty":14.088465,"marketCap":44142287},{"date":"2024-12-20","current":-7.07266,"twenty":-10.789111,"median":-8.479449,"eighty":13.954351,"marketCap":51978012},{"date":"2024-12-27","current":-6.747673,"twenty":-10.659517,"median":-8.390726,"eighty":13.571165,"marketCap":49589633},{"date":"2025-01-03","current":-6.517639,"twenty":-10.562175,"median":-8.162579,"eighty":13.520073,"marketCap":47899077},{"date":"2025-01-10","current":-5.904214,"twenty":-10.499761,"median":-8.051056,"eighty":13.363605,"marketCap":43390929},{"date":"2025-01-17","current":-6.07035,"twenty":-10.463782,"median":-7.83254,"eighty":13.258229,"marketCap":44611886},{"date":"2025-01-24","current":-6.006451,"twenty":-10.451708,"median":-7.712623,"eighty":13.14966,"marketCap":44142287},{"date":"2025-01-31","current":-5.878654,"twenty":-10.421318,"median":-7.617562,"eighty":12.926135,"marketCap":43203089},{"date":"2025-02-07","current":-5.878654,"twenty":-10.364245,"median":-7.402632,"eighty":5.571028,"marketCap":43203089},{"date":"2025-02-14","current":-5.955332,"twenty":-10.299629,"median":-7.207741,"eighty":-5.38422,"marketCap":43766608},{"date":"2025-02-21","current":-6.249265,"twenty":-10.231108,"median":-7.041606,"eighty":-5.510713,"marketCap":45926762},{"date":"2025-02-28","current":-6.380056,"twenty":-10.13985,"median":-6.713492,"eighty":-5.574659,"marketCap":46887966},{"date":"2025-03-07","current":-6.326216,"twenty":-10.13478,"median":-6.696682,"eighty":-5.743169,"marketCap":46492287},{"date":"2025-03-14","current":-5.532074,"twenty":-10.112497,"median":-6.684888,"eighty":-5.743169,"marketCap":40656021},{"date":"2025-03-21","current":-6.110856,"twenty":-10.104487,"median":-6.616553,"eighty":-5.743169,"marketCap":44909571},{"date":"2025-03-28","current":-4.234631,"twenty":-10.098885,"median":-6.511249,"eighty":-5.532216,"marketCap":47178021},{"date":"2025-04-04","current":-4.894342,"twenty":-10.073941,"median":-6.460817,"eighty":-4.926436,"marketCap":54527860},{"date":"2025-04-11","current":-4.279206,"twenty":-10.051126,"median":-6.404799,"eighty":-4.716041,"marketCap":47674632},{"date":"2025-04-17","current":-4.680381,"twenty":-10.000427,"median":-6.391338,"eighty":-4.680381,"marketCap":52144128},{"date":"2025-04-25","current":-5.429242,"twenty":-9.949728,"median":-6.352149,"eighty":-4.680381,"marketCap":60487189},{"date":"2025-05-02","current":-4.733871,"twenty":-9.769745,"median":-6.319486,"eighty":-4.680381,"marketCap":52740061},{"date":"2025-05-09","current":-5.121942,"twenty":-9.696231,"median":-6.287604,"eighty":-4.698211,"marketCap":57063554},{"date":"2025-05-16","current":-59.867974,"twenty":-10.063801,"median":-6.319486,"eighty":-4.716041,"marketCap":56216028},{"date":"2025-05-23","current":-62.521698,"twenty":-10.1145,"median":-6.352149,"eighty":-4.716041,"marketCap":58707874},{"date":"2025-05-30","current":-61.035612,"twenty":-10.269158,"median":-6.380056,"eighty":-4.730305,"marketCap":57312440},{"date":"2025-06-06","current":-63.15859,"twenty":-10.460251,"median":-6.404799,"eighty":-4.739577,"marketCap":59305916},{"date":"2025-06-13","current":-62.893218,"twenty":-10.844881,"median":-6.460817,"eighty":-4.756693,"marketCap":59056732},{"date":"2025-06-20","current":-61.035612,"twenty":-11.364397,"median":-6.504859,"eighty":-4.787361,"marketCap":57312440},{"date":"2025-06-27","current":-65.069271,"twenty":-11.941393,"median":-6.601297,"eighty":-4.858682,"marketCap":61100045},{"date":"2025-07-03","current":-63.052442,"twenty":-12.946571,"median":-6.683774,"eighty":-4.897908,"marketCap":59206243},{"date":"2025-07-11","current":-62.585387,"twenty":-13.494265,"median":-6.687561,"eighty":-4.963879,"marketCap":58767678},{"date":"2025-07-18","current":-56.365062,"twenty":-13.727859,"median":-6.706215,"eighty":-5.054812,"marketCap":52926793},{"date":"2025-07-25","current":-57.320401,"twenty":-14.163867,"median":-6.747673,"eighty":-5.06551,"marketCap":53823857},{"date":"2025-08-01","current":-58.806486,"twenty":-14.540367,"median":-7.140201,"eighty":-5.097711,"marketCap":55219290},{"date":"2025-08-08","current":-57.851146,"twenty":-16.339423,"median":-7.348318,"eighty":-5.123618,"marketCap":54322226},{"date":"2025-08-15","current":-4.477661,"twenty":-17.151414,"median":-7.290809,"eighty":-5.06551,"marketCap":56378234},{"date":"2025-08-22","current":-4.477661,"twenty":-16.339423,"median":-7.07266,"eighty":-4.840851,"marketCap":56378234},{"date":"2025-08-29","current":-4.176437,"twenty":-15.621008,"median":-6.732661,"eighty":-4.723173,"marketCap":52585516},{"date":"2025-09-05","current":-4.298555,"twenty":-15.168225,"median":-6.706215,"eighty":-4.683947,"marketCap":54123104},{"date":"2025-09-12","current":-4.152013,"twenty":-15.047483,"median":-6.687561,"eighty":-4.603418,"marketCap":52277998},{"date":"2025-09-19","current":-3.671682,"twenty":-14.552441,"median":-6.683774,"eighty":-4.480762,"marketCap":46230151},{"date":"2025-09-26","current":-4.054319,"twenty":-14.495088,"median":-6.586042,"eighty":-4.445795,"marketCap":51047928},{"date":"2025-10-03","current":-4.274131,"twenty":-14.455909,"median":-6.482838,"eighty":-4.363684,"marketCap":53815587},{"date":"2025-10-10","current":-4.670023,"twenty":-14.397862,"median":-6.433897,"eighty":-4.347636,"marketCap":58800259},{"date":"2025-10-17","current":-4.092547,"twenty":-14.188422,"median":-6.402621,"eighty":-4.323139,"marketCap":51529260},{"date":"2025-10-24","current":-4.322701,"twenty":-14.088758,"median":-6.364249,"eighty":-4.310147,"marketCap":54427122},{"date":"2025-10-31","current":-4.008855,"twenty":-14.036759,"median":-6.339182,"eighty":-4.297619,"marketCap":50475491},{"date":"2025-11-07","current":-3.448117,"twenty":-13.827869,"median":-6.299296,"eighty":-4.264361,"marketCap":43415245},{"date":"2025-11-14","current":-3.280733,"twenty":-13.729853,"median":-6.273601,"eighty":-4.236343,"marketCap":41307709},{"date":"2025-11-21","current":-2.15737,"twenty":-13.721878,"median":-6.249265,"eighty":-4.197811,"marketCap":40096880},{"date":"2025-11-28","current":-2.444254,"twenty":-13.721878,"median":-6.245456,"eighty":-4.152013,"marketCap":45428912},{"date":"2025-12-05","current":-1.990977,"twenty":-13.591882,"median":-6.147028,"eighty":-4.102049,"marketCap":37004302},{"date":"2025-12-12","current":-1.801633,"twenty":-13.505217,"median":-6.121468,"eighty":-4.090954,"marketCap":33485160},{"date":"2025-12-19","current":-1.524503,"twenty":-13.477836,"median":-6.11051,"eighty":-4.06246,"marketCap":28334418},{"date":"2025-12-26","current":-1.399995,"twenty":-13.199304,"median":-6.089519,"eighty":-4.041726,"marketCap":26020316},{"date":"2026-01-02","current":-1.097619,"twenty":-13.112179,"median":-6.083129,"eighty":-3.997732,"marketCap":20400354},{"date":"2026-01-09","current":-1.503274,"twenty":-13.019016,"median":-6.07035,"eighty":-3.774262,"marketCap":27939847},{"date":"2026-01-16","current":-1.543438,"twenty":-12.937515,"median":-6.048407,"eighty":-3.438074,"marketCap":28686332},{"date":"2026-01-23","current":-1.698355,"twenty":-12.675928,"median":-6.046598,"eighty":-3.349361,"marketCap":31565629},{"date":"2026-01-30","current":-2.031141,"twenty":-12.246297,"median":-6.019231,"eighty":-2.444254,"marketCap":37750786},{"date":"2026-02-06","current":-1.433355,"twenty":-12.01082,"median":-6.006451,"eighty":-2.225304,"marketCap":26640343},{"date":"2026-02-13","current":-0.98652,"twenty":-11.747964,"median":-6.006451,"eighty":-2.15737,"marketCap":18335458},{"date":"2026-02-20","current":-1.003929,"twenty":-11.605851,"median":-5.962795,"eighty":-2.0036,"marketCap":18659025},{"date":"2026-02-27","current":-1.050353,"twenty":-11.364849,"median":-5.922833,"eighty":-1.871633,"marketCap":19521870},{"date":"2026-03-06","current":-0.91108,"twenty":-11.364698,"median":-5.904214,"eighty":-1.792453,"marketCap":16933335},{"date":"2026-03-13","current":-0.905277,"twenty":-11.321986,"median":-5.880344,"eighty":-1.689175,"marketCap":16825479},{"date":"2026-03-20","current":-1.439158,"twenty":-11.110513,"median":-5.878654,"eighty":-1.646716,"marketCap":26748198},{"date":"2026-03-27","current":-1.467538,"twenty":-10.914992,"median":-5.860708,"eighty":-1.608363,"marketCap":28150322},{"date":"2026-04-02","current":-1.360964,"twenty":-10.82151,"median":-5.792072,"eighty":-1.560651,"marketCap":26106017},{"date":"2026-04-10","current":-1.283929,"twenty":-10.659517,"median":-5.747183,"eighty":-1.531962,"marketCap":24628318},{"date":"2026-04-17","current":-1.277509,"twenty":-10.537839,"median":-5.619103,"eighty":-1.503274,"marketCap":24505176},{"date":"2026-04-24","current":-1.245411,"twenty":-10.474376,"median":-5.532074,"eighty":-1.457259,"marketCap":23889468},{"date":"2026-05-01","current":-1.168375,"twenty":-10.45672,"median":-5.366406,"eighty":-1.411471,"marketCap":22411769},{"date":"2026-05-08","current":-1.405823,"twenty":-10.444191,"median":-5.170707,"eighty":-1.405823,"marketCap":26966496},{"date":"2026-05-15","current":-1.33592,"twenty":-10.387009,"median":-5.152877,"eighty":-1.38852,"marketCap":25625621},{"date":"2026-05-22","current":-1.32194,"twenty":-10.330099,"median":-5.121942,"eighty":-1.360964,"marketCap":28113690},{"date":"2026-05-29","current":-1.366074,"twenty":-10.269158,"median":-5.054812,"eighty":-1.357002,"marketCap":29052303},{"date":"2026-06-01","current":-1.289014,"twenty":-10.253923,"median":-5.054812,"eighty":-1.348125,"marketCap":27413455}],"updateTime":1780419395570},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SER\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638540078","title":"Serina Therapeutics director Karen J. Wilson acquires USD 37,000 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2638540078","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638540078?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:27","pubTimestamp":1779827248,"startTime":"0","endTime":"0","summary":"Serina Therapeutics director Karen J. Wilson bought 20,000 common shares in open-market purchases priced at USD 1.77 to USD 1.93.Wilson’s direct holding rose to 20,000 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLbPRCbM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Serina Therapeutics director Karen J. Wilson acquires USD 37,000 common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637342849","title":"Serina Therapeutics director Richard Peter Marshall buys USD 20,102 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2637342849","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637342849?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:00","pubTimestamp":1779483619,"startTime":"0","endTime":"0","summary":"The shares were purchased at a weighted average price of USD 1.65.Marshall’s direct holding rose to 12,183 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL6tkj05:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Serina Therapeutics director Richard Peter Marshall buys USD 20,102 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637445223","title":"Serina Therapeutics files to sell 16.45M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2637445223","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637445223?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:06","pubTimestamp":1779480380,"startTime":"0","endTime":"0","summary":"16:01 EDT Serina Therapeutics (SER) files to sell 16.45M shares of common stock for holders Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-files-to-sell-16-45m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-files-to-sell-16-45m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","SER","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637417533","title":"Serina Therapeutics Inc - Files to Register Resale of up to 16.5 Mln Common Shares by Selling Stockholder- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637417533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637417533?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:02","pubTimestamp":1779480126,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636407728","title":"Serina Therapeutics (SER) Gets a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636407728","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636407728?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:55","pubTimestamp":1779119711,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Serina Therapeutics, with a price target of $11.00. According...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/serina-therapeutics-ser-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/serina-therapeutics-ser-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635578750","title":"Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635578750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635578750?lang=en_us&edition=fundamental","pubTime":"2026-05-16 14:00","pubTimestamp":1778911257,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc. (SER) has disclosed a new risk, in the Share Price & Shareholder Rights category. The March 2026 PIPE involving director ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/insider-backed-pipe-deal-may-dilute-serina-therapeutics-shareholders-and-heighten-governance-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/insider-backed-pipe-deal-may-dilute-serina-therapeutics-shareholders-and-heighten-governance-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","PIPE","SER","BK4007","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635721462","title":"Serina Therapeutics: Q1 EPS $-0.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2635721462","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635721462?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:20","pubTimestamp":1778790000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA7RCJ7T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635214527","title":"Serina Therapeutics:  Ser-252 Phase 1B Registrational Study Underway in Advanced Parkinson's Disease; Tfl Data Targeted for H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2635214527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635214527?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:20","pubTimestamp":1778790000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA7RCJ7T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723544","title":"Serina Therapeutics Q1 FY26 net loss widens to $6.9 million from Q1 FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723544","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723544?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789108,"startTime":"0","endTime":"0","summary":"Serina Therapeutics posted a net loss of USD 6.9 million for quarter ended March 31, 2026, widening from USD 4.82 million year earlier.Operating loss widened to USD 6.28 million as operating expenses rose to USD 6.28 million, led by research and development costs of USD 3.2 million.Other expense swung to USD 611,000 from other income of USD 1.04 million, driven by a non-cash loss tied to amendment of convertible notes in connection with March 2026 PIPE.Cash and cash equivalents totaled USD 24.5 million at March 31, 2026; net cash used in operating activities was USD 4.57 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL6Vhn6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632305519","title":"Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2632305519","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632305519?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892400,"startTime":"0","endTime":"0","summary":"Data highlight both SER-603’s rational design that targets microbial functions linked to mucosal healing and gastrointestinal inflammation in IBD, as well as the advancement of microbiome-based biomar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3286554/0/en/Seres-Therapeutics-Presents-Preclinical-Data-at-Digestive-Disease-Week-DDW-2026-Supporting-SER-603-a-Next-Generation-Cultivated-Live-Biotherapeutic-Candidate-for-Inflammatory-Bowel.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MCRB","SER","IBD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629709257","title":"SER Industries Gets BSE's Approval for Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709257","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629709257?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:28","pubTimestamp":1776839328,"startTime":"0","endTime":"0","summary":"Logistic service provider SER Industries  has received approval from the BSE stock exchange to \"Desi Farms India\" with effect from April 21, according to a same-day filing to the BSE.The company's equity shares will be traded under scrip ID \"DESIFARMS\" with effect from April 27.The company's shares were up 2% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BSE","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629063480","title":"Serina Therapeutics names Srini Tenjarla chief technology officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629063480","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629063480?lang=en_us&edition=fundamental","pubTime":"2026-04-22 05:13","pubTimestamp":1776805990,"startTime":"0","endTime":"0","summary":"Serina Therapeutics named Srini Tenjarla chief technology officer on April 20, 2026.Tenjarla previously served as senior vice president of CMC and formulation at Serina  since July 2024.Company raised base salary for CEO Steve Ledger on April 15, 2026, tied to strategic goals under his employment agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL7CBsWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628174260","title":"Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628174260","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628174260?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682800,"startTime":"0","endTime":"0","summary":"Pharmacologic data highlight durable GI microbiome modulation, with improvement in epithelial barrier integrity, following SER-155 administration Additional presentations underscore the role of live b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276845/0/en/Seres-Therapeutics-Showcases-SER-155-Data-and-Live-Biotherapeutic-Insights-at-ESCMID-Global-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4006","BK4585","IBD","BK4588","SER","MCRB","AMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625934477","title":"Serina Therapeutics presents POZ-based lipid nanoparticle data at LNP formulation summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2625934477","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625934477?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:46","pubTimestamp":1775558775,"startTime":"0","endTime":"0","summary":"Serina to present at 5th LNP Formulation & Process Development Summit in Boston, Massachusetts.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL636Zt1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","SER","BK4585","LU2095319765.USD","BK4112","SG9999014039.USD","IE00B64PRP62.GBP","BK4588","BK4139","LU0314104364.USD","LU2210150020.SGD","NDAQ","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624805646","title":"BRIEF-Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2624805646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624805646?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:34","pubTimestamp":1775165692,"startTime":"0","endTime":"0","summary":"BRIEF-Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance PlanApril 2 (Reuters) - Serina Therapeutics Inc SER.A:SERINA THERAPEUTICS ANNOUNCES NYSE AMERICAN ACCEPTANC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA8JYXP2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624823066","title":"NYSE American accepts Serina plan to regain listing compliance by July 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2624823066","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624823066?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:13","pubTimestamp":1775160821,"startTime":"0","endTime":"0","summary":"NYSE American accepted Serina Therapeutics’ plan to regain compliance with continued listing standards.Cure period runs through July 9, 2027, with shares remaining listed during that time subject to other standards.Company received a noncompliance notice on Jan. 9, 2026 tied to stockholders’ equity of $1.6 million.NYSE American will monitor progress quarterly, with suspension and delisting procedures possible if targets are not met by deadline.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4thyMN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","SG9999014021.USD","BK4585","BK4588","SG9999014013.SGD","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4112","SER","LU0314104364.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4139","NDAQ","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624682341","title":"Serina Therapeutics Announces Nyse American Acceptance of Continued Listing Compliance Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2624682341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624682341?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:13","pubTimestamp":1775160780,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA8JYXP2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622016822","title":"Analysts’ Top Healthcare Picks: Serina Therapeutics (SER), Pharma Mar SA (PHMMF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622016822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622016822?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:40","pubTimestamp":1774618806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Serina Therapeutics (SER) and Pharma Mar SA (PHMMF) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-serina-therapeutics-ser-pharma-mar-sa-phmmf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-serina-therapeutics-ser-pharma-mar-sa-phmmf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","SER","BK4585","BK4139","LU0029874061.USD","HCSG","LU0128526141.USD","BK4137","PHMMF","XBI","BK4588","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622047250","title":"Serina Therapeutics, Inc FY Revenue USD 130 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2622047250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622047250?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:20","pubTimestamp":1774470000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nPLXAE51EF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622045250","title":"Serina Therapeutics FY2025 net loss widens 71.46% to $(19.2) million; revenue rises more than doubled to $130,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2622045250","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622045250?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:04","pubTimestamp":1774469078,"startTime":"0","endTime":"0","summary":"Serina published its annual report on Form 10-K, reporting a net loss of USD 19.2 million and grant revenues of USD 130,000.Research and development expense rose 75.9% to USD 13.2 million, driven mainly by higher clinical activities, increased headcount-related compensation, and higher consultant and outsourced research spend.General and administrative expense increased 14.3% to USD 11.0 million, primarily due to higher stock-based compensation, public company infrastructure consulting, and investor outreach, partly offset by lower legal and certain professional fees.Cash and cash equivalents were USD 3.1 million, and net cash used in operating activities was USD 18.0 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Thera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL8FzlHq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}